Thiogenesis Therapeutics, Corp. to Present at the Life Sciences Virtual Investor Forum December 11th
(TSX-V:TTI),(Other OTC:TTIPF), SAN DIEGO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) (“Thiogenesis” or the “Company”), a clinical-stage biotechnology company developing next-generation sulfur-based prodrugs for rare mitochondrial and metabolic diseases, today announced that Brook Riggins, CFO and director, will present live at Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, […]